Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1986 Sep 1;164(3):938–943. doi: 10.1084/jem.164.3.938

HLA-DO polymorphism associated with resistance to type I diabetes detected with monoclonal antibodies, isoelectric point differences, and restriction fragment length polymorphism

PMCID: PMC2188401  PMID: 3462303

Abstract

A new HLA-DQ-related genetic system with two alleles, 2B3 and TA10, defined serologically by MAbs and alloantisera, showed an almost perfect correlation with charge differences on DQ beta molecules, as well as with two polymorphic DNA fragments hybridizing with a DQ beta probe and various restriction enzymes on a panel of 14 DR4+ homozygous typing cells. It was therefore concluded that the serologically defined alleles 2B3 and TA10 are coded by the DQ beta gene and situated on the HLA-DQ beta chain. This 2B3/TA10 polymorphism is independent of HLA-D and segregates with HLA in families. The TA10 allele appears to be a new marker for resistance to type I diabetes, which is independent from the known resistance marker DR2, whereas no association was observed between this DQ beta polymorphism and rheumatoid arthritis.

Full Text

The Full Text of this article is available as a PDF (355.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bruning J. W., Claas F. H., Kardol M. J., Lansbergen Q., Naipal A. M., Tanke H. J. Automated reading of HLA-A,B,C typing and screening. The propidium iodide (PI) method. Hum Immunol. 1982 Nov;5(3):225–231. doi: 10.1016/0198-8859(82)90135-5. [DOI] [PubMed] [Google Scholar]
  2. Contu L., Deschamps I., Lestradet H., Hors J., Schmid M., Busson M., Benajam A., Marcelli-Barge A., Dausset J. HLA haplotype study of 53 juvenile insulin-dependent diabetic (I.D.D.) families. Tissue Antigens. 1982 Aug;20(2):123–140. doi: 10.1111/j.1399-0039.1982.tb00335.x. [DOI] [PubMed] [Google Scholar]
  3. Goyert S. M., Shively J. E., Silver J. Biochemical characterization of a second family of human Ia molecules, HLA-DS, equivalent to murine I-A subregion molecules. J Exp Med. 1982 Aug 1;156(2):550–566. doi: 10.1084/jem.156.2.550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kim S. J., Holbeck S. L., Nisperos B., Hansen J. A., Maeda H., Nepom G. T. Identification of a polymorphic variant associated with HLA-DQw3 and characterized by specific restriction sites within the DQ beta-chain gene. Proc Natl Acad Sci U S A. 1985 Dec;82(23):8139–8143. doi: 10.1073/pnas.82.23.8139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Koning F., Raghoebar J., Schreuder G. M., Schuurman R., Bruning H. A monoclonal antibody detecting an HLA-DQwl-related determinant. Tissue Antigens. 1985 Aug;26(2):100–109. doi: 10.1111/j.1399-0039.1985.tb00941.x. [DOI] [PubMed] [Google Scholar]
  6. Maeda H. Mouse monoclonal antibody detects a new polymorphic Ia determinant other than HLA-DR antigen: a possible allele of DC-1. Tissue Antigens. 1984 Mar;23(3):163–170. doi: 10.1111/j.1399-0039.1984.tb00027.x. [DOI] [PubMed] [Google Scholar]
  7. Owerbach D., Lernmark A., Platz P., Ryder L. P., Rask L., Peterson P. A., Ludvigsson J. HLA-D region beta-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature. 1983 Jun 30;303(5920):815–817. doi: 10.1038/303815a0. [DOI] [PubMed] [Google Scholar]
  8. Raum D., Awdeh Z., Yunis E. J., Alper C. A., Gabbay K. H. Extended major histocompatibility complex haplotypes in type I diabetes mellitus. J Clin Invest. 1984 Aug;74(2):449–454. doi: 10.1172/JCI111441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Schreuder G. M., Maeda H., Koning F., D'Amaro J. TA10 and 2B3, two new alleles in the HLA-DQ region recognized by monoclonal antibodies. Hum Immunol. 1986 Jun;16(2):127–136. doi: 10.1016/0198-8859(86)90041-8. [DOI] [PubMed] [Google Scholar]
  10. Spits H., Borst J., Giphart M., Coligan J., Terhorst C., De Vries J. E. HLA-DC antigens can serve as recognition elements for human cytotoxic T lymphocytes. Eur J Immunol. 1984 Apr;14(4):299–304. doi: 10.1002/eji.1830140404. [DOI] [PubMed] [Google Scholar]
  11. Tilanus M. G., Morolli B., van Eggermond M. C., Schreuder G. M., de Vries R. R., Giphart M. J. Dissection of HLA class II haplotypes in HLA-DR4 homozygous individuals. Immunogenetics. 1986;23(5):333–340. doi: 10.1007/BF00398798. [DOI] [PubMed] [Google Scholar]
  12. de Jongh B. M., Termijtelen A., Bruining G. J., de Vries R. R., van Rood J. J. Relation of insulin-dependent diabetes mellitus (IDD) and the HLA-linked SB system. Tissue Antigens. 1984 Feb;23(2):87–93. doi: 10.1111/j.1399-0039.1984.tb00015.x. [DOI] [PubMed] [Google Scholar]
  13. van Rood J. J., van Leeuwen A., Ploem J. S. Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants. Nature. 1976 Aug 26;262(5571):795–797. doi: 10.1038/262795a0. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES